The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Treating Oxidative Stress in Heart Failure: Past, Present and Future
Open accessAbstract
Advances in cardiovascular research have identified oxidative stress as an important pathophysiological pathway in the development and progression of heart failure. Oxidative stress is defined as the imbalance between the production of reactive oxygen species (ROS) and the endogenous antioxidant defence system. Under physiological conditions, small quantities of ROS are produced intracellularly, which function in cell signalling, and can be readily reduced by the antioxidant defence system. However, under pathophysiological conditions, the production of ROS exceeds the buffering capacity of the antioxidant defence system, resulting in cell damage and death. Over the last decades several studies have tried to target oxidative stress with the aim to improve outcome in patients with heart failure, with very limited success. The reasons as to why these studies failed to demonstrate any beneficial effects remain unclear. However, one plausible explanation might be that currently employed strategies, which target oxidative stress by exogenous inhibition of ROS production or supplementation of exogenous antioxidants, are not effective enough, while bolstering the endogenous antioxidant capacity might be a far more potent avenue for therapeutic intervention. In this review, we provide an overview of oxidative stress in the pathophysiology of heart failure and the strategies utilized to date to target this pathway. We provide novel insights into modulation of endogenous antioxidants, which may lead to novel therapeutic strategies to improve outcome in patients with heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationStephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
The importance of glutathione in human disease
Townsend, D. M., Tew, K. D., & Tapiero, H. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00043-x · Cited by 2,004
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
Increased myocardial NADPH oxidase activity in human heart failure
Heymes, C., Bendall, J. K., Ratajczak, P., Cave, A. C., Samuel, J.-L., Hasenfuss, G., & Shah, A. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00471-6 · Cited by 579
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Myung, S.-K., Ju, W., Cho, B., Oh, S.-W., Park, S. M., Koo, B.-K., Park, B.-J., & for the Korean Meta-Analysis (KORMA) Study Group (2013) · BMJ · doi:10.1136/bmj.f10 · Cited by 467
Takimoto, E., Champion, H. C., Li, M., Ren, S., Rodriguez, E. R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K. L., Wang, Y., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521968 · Cited by 450
Yang, K.-C., Yamada, K. A., Patel, A. Y., Topkara, V. K., George, I., Cheema, F. H., Ewald, G. A., Mann, D. L., & Nerbonne, J. M. (2014) · Circulation · doi:10.1161/circulationaha.113.003863 · Cited by 449
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M. (2001) · Circulation · doi:10.1161/hc4501.098928 · Cited by 436
A Trial of Antioxidants N-acetylcysteine and Procysteine in ARDS
Bernard, G. R., Wheeler, A. P., Arons, M. M., Morris, P. E., Paz, H. L., Russell, J. A., & Wright, P. E. (1997) · Chest · doi:10.1378/chest.112.1.164 · Cited by 430
Role of oxidative stress in transition of hypertrophy to heart failure
Dhalla, A. K., Hill, M. F., & Singal, P. K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00140-4 · Cited by 427
Impact of Oxypurinol in Patients With Symptomatic Heart Failure
Hare, J. M., Mangal, B., Brown, J., Fisher, C., Freudenberger, R., Colucci, W. S., Mann, D. L., Liu, P., Givertz, M. M., & Schwarz, R. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.068 · Cited by 392
Pillai, J. B., Isbatan, A., Imai, S.-I., & Gupta, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506162200 · Cited by 391
Hill, M. F., & Singal, P. K. (1996) · Europe PMC (PubMed Central) · Cited by 363
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
Diguet, N., Trammell, S. A. J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., Gouge, A., Gressette, M., Manoury, B., Blanc, J., et al. (2018) · Circulation · doi:10.1161/circulationaha.116.026099 · Cited by 358
Perrelli, M.-G. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i6.186 · Cited by 335
Zsebo, K., Yaroshinsky, A., Rudy, J. J., Wagner, K., Greenberg, B., Jessup, M., & Hajjar, R. J. (2014) · Circulation Research · doi:10.1161/circresaha.113.302421 · Cited by 315
Rajamohan, S. B., Pillai, V. B., Gupta, M., Sundaresan, N. R., Birukov, K. G., Samant, S., Hottiger, M. O., & Gupta, M. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00121-09 · Cited by 302
VÁSQUEZ-VIVAR, J., MARTÁSEK, P., WHITSETT, J., JOSEPH, J., & KALYANARAMAN, B. (2002) · Biochemical Journal · doi:10.1042/bj3620733 · Cited by 287
Hsu, C.-P., Oka, S., Shao, D., Hariharan, N., & Sadoshima, J. (2009) · Circulation Research · doi:10.1161/circresaha.109.203703 · Cited by 284
Shiomi, T., Tsutsui, H., Matsusaka, H., Murakami, K., Hayashidani, S., Ikeuchi, M., Wen, J., Kubota, T., Utsumi, H., & Takeshita, A. (2004) · Circulation · doi:10.1161/01.cir.0000109701.77059.e9 · Cited by 260
Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury
Wang, P., Chen, H., Qin, H., Sankarapandi, S., Becher, M. W., Wong, P. C., & Zweier, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4556 · Cited by 258
Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases
Hershberger, K. A., Martin, A. S., & Hirschey, M. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.5 · Cited by 218
Doerries, C., Grote, K., Hilfiker-Kleiner, D., Luchtefeld, M., Schaefer, A., Holland, S. M., Sorrentino, S., Manes, C., Schieffer, B., Drexler, H., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000261657.76299.ff · Cited by 206
Forgione, M. A., Cap, A., Liao, R., Moldovan, N. I., Eberhardt, R. T., Lim, C. C., Jones, J., Goldschmidt-Clermont, P. J., & Loscalzo, J. (2002) · Circulation · doi:10.1161/01.cir.0000026820.87824.6a · Cited by 200
Yoshida, T. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0165 · Cited by 178
Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy
Minhas, K. M., Saraiva, R. M., Schuleri, K. H., Lehrke, S., Zheng, M., Saliaris, A. P., Berry, C. E., Vandegaer, K. M., Li, D., & Hare, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000200181.59551.71 · Cited by 170
Cunnington, C., Van Assche, T., Shirodaria, C., Kylintireas, I., Lindsay, A. C., Lee, J. M., Antoniades, C., Margaritis, M., Lee, R., Cerrato, R., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.038919 · Cited by 166
Arstall, M. A., Yang, J., Stafford, I., Betts, W. H., & Horowitz, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.10.2855 · Cited by 155
Mitochondrial Oxidative Stress in Heart Failure: “Oxygen Wastage” Revisited
Sawyer, D. B., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.2.119 · Cited by 146
Damy, T., Kirsch, M. E. W., Khouzami, L., Caramelle, P., Corvoisier, P. L., Roudot‐Thoraval, F., Dubois‐Randé, J., Hittinger, L., Pavoine, C., & Pecker, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004871 · Cited by 118
Cingolani, H. E., Plastino, J. A. M., Escudero, E. M., Mangal, B., Brown, J., & Pérez, N. G. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.05.005 · Cited by 117
Ukai, T., Cheng, C., Tachibana, H., Igawa, A., Zhang, Z.-S., Cheng, H.-J., & Little, W. C. (2001) · Circulation · doi:10.1161/01.cir.103.5.750 · Cited by 115
Singh, R. B., Niaz, M. A., Rastogi, S. S., & Rastogi, S. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89384-8 · Cited by 114
Role of Oxidative Stress in Cardiac Remodelling after Myocardial Infarction
Grieve, D., Byrne, J., Cave, A. C., & Shah, A. M. (2004) · Heart Lung and Circulation · doi:10.1016/j.hlc.2004.02.008 · Cited by 106
Gavin, A. D., & Struthers, A. D. (2005) · Heart · doi:10.1136/hrt.2004.040477 · Cited by 106
van Deel, E. D., Lu, Z., Xu, X., Zhu, G., Hu, X., Oury, T. D., Bache, R. J., Duncker, D. J., & Chen, Y. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.007 · Cited by 104
von Lueder, T. G., Girerd, N., Atar, D., Agewall, S., Lamiral, Z., Kanbay, M., Pitt, B., Dickstein, K., Zannad, F. M., Rossignol, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.419 · Cited by 101
Oxidative Stress as a Mechanism of Cardiac Failure in Chronic Volume Overload in Canine Model
Prasad, K. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0035 · Cited by 96
Guan, W., Osanai, T., Kamada, T., Hanada, H., Ishizaka, H., Onodera, H., Iwasa, A., Fujita, N., Kudo, S., Ohkubo, T., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200305000-00005 · Cited by 91
Qin, F., Lennon, S. L., Lancel, S., Biolo, A., Siwik, D. A., Pimentel, D. R., Dorn, G. W., Kang, Y. J., & Colucci, W. S. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.864785 · Cited by 88
NAMPT as a Therapeutic Target against Stroke
Wang, P., & Miao, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.012 · Cited by 87
Adamy, C., Mulder, P. G. H., Khouzami, L., Andrieu‐Abadie, N., Defer, N., Candiani, G., Pavoine, C., Caramelle, P., Souktani, R., Corvoisier, P. L., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.06.010 · Cited by 86
Redox biomarkers in cardiovascular medicine
Galougahi, K. K., Antoniades, C. A., Nicholls, S. J., Channon, K. M., & Figtree, G. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv126 · Cited by 83
Bourraindeloup, M., Adamy, C., Candiani, G., Cailleret, M., Bourin, M., Badoual, T., Su, J. B., Adubeiro, S., Roudot‐Thoraval, F., Dubois‐Randé, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143630.14515.7c · Cited by 81
Zarka, M. H., & Bridge, W. J. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.014 · Cited by 79
Schupp, N., Schmid, U., Heidland, A., & Stopper, H. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.016 · Cited by 78
Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction
Khaper, N., Kaur, K., Li, T., Farahmand, F., & Singal, P. K. (2003) · Springer eBooks · doi:10.1007/978-1-4419-9238-3_2 · Cited by 77
Khaper, N., & Singal, P. K. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00574-8 · Cited by 76
Mericskay, M. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.10.004 · Cited by 69
SOCHMAN, J., Vrbská, J., Musilová, B., & Roček, M. (1996) · Clinical Cardiology · doi:10.1002/clc.4960190205 · Cited by 66
Raising NAD in Heart Failure: Time to Translate?
Walker, M. A., & Tian, R. (2018) · Circulation · doi:10.1161/circulationaha.117.032626 · Cited by 65
Molecular and Structural Transition Mechanisms in Long-Term Volume Overload
Mohamed, B. A., Schnelle, M., Khadjeh, S., Lbik, D., Herwig, M., Linke, W. A., Hasenfuss, G. P., & Toischer, K. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.465 · Cited by 64
Cardiac troponin and heart failure in the era of high-sensitivity assays
Sato, Y., Fujiwara, H., & Takatsu, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.06.007 · Cited by 62
van der Pol, A., Gil, A., Tromp, J., Silljé, H. H. W., van Veldhuisen, D. J., Voors, A. A., Hoendermis, E. S., Beverborg, N. G., Schouten, E., de Boer, R. A., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy187 · Cited by 62
Self-citationHamblin, M., Smith, H., & Hill, M. F. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.002 · Cited by 61
Wolfram, R. M., Oguogho, A., Palumbo, B., & Sinzinger, H. F. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.05.007 · Cited by 60
Freudenberger, R. S., Schwarz, R. P., Jr., Brown, J., Moore, A., Mann, D. L., Givertz, M. M., Colucci, W. S., & Hare, J. M. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.11.1509 · Cited by 58
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH
van der Pol, A., Gil, A., Silljé, H., Tromp, J., Ovchinnikova, E., Vreeswijk-Baudoin, I., Hoes, M., Domian, I., van de Sluis, B., van Deursen, J., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8574 · Cited by 55
Self-citationNew substrates of 5-oxo-L-prolinase.
Williamson, J. M., & Meister, A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33673-1 · Cited by 54
Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits
Ding, Y., Li, Y.-L., Zimmerman, M. C., Davisson, R. L., & Schultz, H. D. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn350 · Cited by 51
5-Oxoproline Reduces Non-Enzymatic Antioxidant Defenses in vitro in Rat Brain
Pederzolli, C. D., Sgaravatti, Â. M., Braum, C. A., Prestes, C. C., Zorzi, G. K., Sgarbi, M., Wyse, Â. T. D. S., Wannmacher, C. M. D., Wajner, M., & Dutra‐Filho, C. S. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-006-9041-2 · Cited by 50
Safety of sapropterin dihydrochloride (6r–bh4) in patients with pulmonary hypertension
Robbins, I. M., Hemnes, A. R., Simon Gibbs, J., Christman, B. W., Howard, L., Meehan, S., Cabrita, I., Gonzalez, R., Oyler, T., Zhao, L., et al. (2011) · Experimental Lung Research · doi:10.3109/01902148.2010.512972 · Cited by 47
Li, W., Tang, R., Ouyang, S., Ma, F., Liu, Z., & Wu, J. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0224-0 · Cited by 44
The response of γ vitamin E to varying dosages of α vitamin E plus vitamin C
Gutierrez, A., de Serna, D. G., Robinson, I., & Schade, D. S. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.003 · Cited by 37
Reverter, E., Mesonero, F., Seijó, S., Martínez, J., Abraldeṣ, J. G., Peñas, B., Berzigotti, A., Deulofeu, R., Bosch, J., Albillos, A., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.185 · Cited by 32
Mehra, A., Shotan, A., Ostrzega, E., Hsueh, W. A., Vasquez-Johnson, J., & Elkayam, U. (1994) · Circulation · doi:10.1161/01.cir.89.6.2595 · Cited by 32
SOCHMAN, J., & PEREGRIN, J. H. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90063-9 · Cited by 24
l -2-Oxothiazolidine-4-Carboxylic Acid Prevents Endotoxin-induced Cardiac Dysfunction
Poon, B. Y., Goddard, C., Leaf, C. D., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9702043 · Cited by 17
The effect of l-2-oxothiazolidine on glutathione levels in cultured mammalian cells
Weitberg, A. B. (1987) · Mutation Research Letters · doi:10.1016/0165-7992(87)90152-7 · Cited by 11
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation
Lu, Y., Li, Z., Zhang, S., Zhang, T., Liu, Y., & Zhang, L. (2023) · Theranostics · doi:10.7150/thno.79876 · Cited by 685
Mitochondrial Oxidative Stress—A Causative Factor and Therapeutic Target in Many Diseases
Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-Ośko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., & Kaczyńska, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413384 · Cited by 495
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
D’Oria, R., Schipani, R., Leonardini, A., Natalicchio, A., Perrini, S., Cignarelli, A., Laviola, L., & Giorgino, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5732956 · Cited by 376
Metadata
- Authors
- van der Pol, A., van Gilst, W. H., Voors, A. A., & van der Meer, P.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-19
- Volume
- 21
- Issue
- 4
- Pages
- 425-435
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2896234395
- Cited by
- 813
- References
- 75
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.